🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsMicro-dosing semaglutide — is sub-therapeutic dosing effective? Page 4

Micro-dosing semaglutide — is sub-therapeutic dosing effective?

Dr.ObesityMed Mon, Jun 8, 2026 at 12:53 AM 16 replies 160 viewsPage 4 of 4
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jun 8, 2026 at 4:29 PM#16

From the other side of the consultation, briefly. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Last edited: Jun 8, 2026 at 10:29 PM
17 17emma_london, tammy_FL, Dr.LipidDallas and 14 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jun 8, 2026 at 5:54 PM#17

Clinical perspective, offered as context rather than as advice. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

16 16PharmD_Rodriguez, julia.endo, JessicaM_2024 and 13 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Jun 8, 2026 at 7:19 PM#18
LibrarianMeg said:
The mechanism and the magnitude are separate questions.

Second this. Nothing to add that would improve it.

Last edited: Jun 8, 2026 at 9:19 PM
15 15stefan_berlin, Dr.EM_Chicago, pete_RVA and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Jun 8, 2026 at 8:44 PM#19
LibrarianMeg said:
The mechanism and the magnitude are separate questions.

Adding the part of the answer the thread has not reached. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

14 14JessicaH_TX, KevinCompounds, TirzTom and 11 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 8, 2026 at 10:09 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

42 17PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 39 others
Reply Quote Save Share Report

Similar Threads

Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
Dose escalation too fast? Recognizing over-titration symptoms5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register